Search Results - david+weiss

5 Results Sort By:
Combination Antibiotic Therapy to Exploit Multiple Heteroresistance
Application Treatment with combinations of FDA-approved antibodies targeting small drug-resistant cell populations for infectious disease. Key Benefits Specific combinations of existing drugs that target small subpopulations of bacterial cells resistant to many standard of care treatment regimens. Potential to overcome the drug resistance crisis...
Published: 8/22/2024   |   Inventor(s): David Weiss, David Hufnagel, Victor Band
Keywords(s): Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Therapeutics
A New Method to Detect and Tackle Antibiotic Heteroresistance
­ Application A method to detect heteroresistance to antibiotics in bacteria. Key Benefits Significantly faster than commercially available options. Aside from the interferometer itself, no specialized reagents are required. Inexpensive to use. Market Summary Antibiotic resistance is a significant threat to public health. Rapid and sensitive...
Published: 7/30/2024   |   Inventor(s): David Weiss, Peter Yunker, David Hufnagel, Arben (Ben) Kalziqi
Keywords(s): Microbiology/Infectious Diseases, Platform
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Research Tools
CRISPR Based System for Targeted Reduction of Gene Expression
Application A CRISPR based gene silencing system using sequence specific RNA to repress expression of endogenous transcripts. Key Benefits Provides a platform to target specific mRNA transcripts in both prokaryotic and eukaryotic cells. Potential therapeutic strategy against pathogenic bacteria and viruses. Market Summary RNAi is an indispensable...
Published: 7/30/2024   |   Inventor(s): David Weiss, Timothy Sampson
Keywords(s): Agriculture, Cell/Gene Therapy, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Research Tools
Cas9 Controlled Gene Activation
Application Flexible system using Cas9 to modulate gene expression. Key Benefits Edits genes by cleaving DNA as well as inhibiting transcription. No need to transfect cells with additional Cas9. Market Summary The CRISPR-Cas9 system is a bacterial adaptive immune system that has been appropriated for genetic engineering. The CRISPR-Cas9 system...
Published: 8/22/2024   |   Inventor(s): David Weiss, Hannah Ratner
Keywords(s): Cell/Gene Therapy, Enzyme/Protein, Genetic Disorders, Platform
Category(s): TechPub Algolia > Therapeutics
Hybrid Plasmonic Platform for Directing and Controlling Nanostructure Growth
Low-Heat, Bottom-Up Approach Can Produce Metal, Polymer or Bio-Molecule Structures for Catalysis, Biosensors, Electronic Devices and MoreThis surface plasmon mediated chemical solution deposition method uses surface plasmon resonance to deposit nanoparticles in the liquid phase at room temperature to direct and control nanostructure growth. Plasmonic...
Published: 6/27/2021   |   Inventor(s): Wei Wei, Jingjing Qiu
Keywords(s): Catalysts, nanoparticle synthesis, Plasmonic, Thin Films
Category(s): Technology Classifications > Engineering > Chemical, Technology Classifications > Engineering > Materials